US Patent 12105090 Methods of treating a multiple sclerosis patient with anti-VLA-4 therapy

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

121050900

Patent Inventor Names

Sophia Lee0

Meena Subramanyam0

Tatiana Plavina0

Carmen Bozic0

Gary Lewis Bloomgren0

Date of Patent

October 1, 2024

Patent Application Number

162111540

Date Filed

December 5, 2018

Patent Citations

‌

US Patent 7026501 Inhibitors of α4 mediated cell adhesion

‌

US Patent 7101855 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4

‌

US Patent 7129053 Immuno-chromatographic rapid assay in order to detect acid-resistant microorganisms in the stool

‌

US Patent 7419666 Treatment of ocular disorders

‌

US Patent 7718444 Convenient detection method, detection apparatus and detection kit

‌

US Patent 7807167 Administration of agents for the treatment of inflammation

‌

US Patent 8410115 Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds

‌

US Patent 9316641 Assay for JC virus antibodies

...

Patent Primary Examiner

‌

Maher M. Haddad

Patent abstract

The invention relates to methods of assessing a patient's risk of developing Progressive multifocal leukoencephalopathy (PML).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 12105090 Methods of treating a multiple sclerosis patient with anti-VLA-4 therapy

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 12105090 Methods of treating a multiple sclerosis patient with anti-VLA-4 therapy